Jagannath Rao

Jagannath Rao

Director Director DIN 06795586
DIN 06795586 First appointment Sep 2014 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Jagannath Rao

Data last updated:

Jagannath Rao was a Director at Riccur Pharma Private Limited (2017–2018) and Director at Farishta International Private Limited (from 2014). The companies operate in Pharma.

DIN 06795586
Primary Designation Director
Industry Pharma
First Appointment 25 Sep 2014
Oldest Company Age 12 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Riccur Pharma Private Limited U24230MH2011PTC223699
Director06 Apr 20172011₹13.30 Cr (FY 2019)Active
Director25 Sep 20142014Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Farishta International Private Limited
Riccur Pharma Private Limited
Premium access

Shareholding and investment profile for Jagannath Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jagannath Rao

Jagannath Rao was first appointed on 25 Sep 2014 as Director at Farishta International Private Limited. The most recent appointment on record is 06 Apr 2017 at Riccur Pharma Private Limited.

Jagannath Rao held 2 earlier board appointments: Riccur Pharma Private Limited (Director, 06 Apr 2017 to 16 Aug 2018); Farishta International Private Limited (Director, from 25 Sep 2014).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available